Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Abstract. Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy. This study will systemically review the progress made in endocrine therapy combined with targeted therapy in the treatment of...
| الحاوية / القاعدة: | Chinese Medical Journal |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Wolters Kluwer
2020-10-01
|
| الوصول للمادة أونلاين: | http://journals.lww.com/10.1097/CM9.0000000000000923 |